<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[FDA-godkendelser i August]]></title><description><![CDATA[<p dir="auto">Her en super god oversigt fra Evaluate Vantage med laegemiddel-kandidater, som FDA har vendt tomlen op og ned til i august:<br />
<a href="https://www.evaluate.com/vantage/articles/news/snippets/us-fda-approval-tracker-august" rel="nofollow ugc">https://www.evaluate.com/vantage/articles/news/snippets/us-fda-approval-tracker-august</a></p>
<p dir="auto">Supplementary and other notable approval decisions in August<br />
Darzalex (+ Kyprolis + dexamethasone) J&amp;J/Genmab Relapsed/refractory multiple myeloma (Candor) Approved</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/441759/fda-godkendelser-i-august</link><generator>RSS for Node</generator><lastBuildDate>Thu, 09 Jul 2026 17:31:02 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/441759.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 03 Sep 2020 20:32:27 GMT</pubDate><ttl>60</ttl></channel></rss>